Literature DB >> 10712679

Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice.

R E Tascon1, C S Soares, S Ragno, E Stavropoulos, E M Hirst, M J Colston.   

Abstract

Activated dendritic cells are critically important in the priming of T-cell responses. In this report we show that the infection of a conditionally immortalized dendritic cell line (tsDC) with Mycobacterium tuberculosis resulted in the up-regulation of B7-1 and B7-2 co-stimulatory molecules and the induction of several inflammatory cytokines, including tumour necrosis factor-alpha and interleukin-6, -1beta and -12. In addition, we show that these activated dendritic cells were capable of eliciting antigen-specific T-cell responses and potent anti-mycobacterial protective immunity in a murine model of experimental tuberculosis infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712679      PMCID: PMC2327172          DOI: 10.1046/j.1365-2567.2000.00963.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells.

Authors:  T Sparwasser; E S Koch; R M Vabulas; K Heeg; G B Lipford; J W Ellwart; H Wagner
Journal:  Eur J Immunol       Date:  1998-06       Impact factor: 5.532

2.  Localization of T cells, macrophages and dendritic cells in rat respiratory tract tissue: implications for immune function studies.

Authors:  P G Holt; M A Schon-Hegrad
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

Review 3.  Immunity to intracellular bacteria.

Authors:  S H Kaufmann
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

4.  Vaccination against tuberculosis by DNA injection.

Authors:  R E Tascon; M J Colston; S Ragno; E Stavropoulos; D Gregory; D B Lowrie
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

5.  Global tuberculosis incidence and mortality during 1990-2000.

Authors:  P J Dolin; M C Raviglione; A Kochi
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

6.  Human resident langerhans cells display a lysosomal compartment enriched in MHC class II.

Authors:  M J Kleijmeer; V M Oorschot; H J Geuze
Journal:  J Invest Dermatol       Date:  1994-10       Impact factor: 8.551

Review 7.  Antituberculous immunity: new solutions to an old problem.

Authors:  F M Collins
Journal:  Rev Infect Dis       Date:  1991 Sep-Oct

8.  Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells.

Authors:  H W Nijman; M J Kleijmeer; M A Ossevoort; V M Oorschot; M P Vierboom; M van de Keur; P Kenemans; W M Kast; H J Geuze; C J Melief
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

9.  Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant.

Authors:  J C Guéry; F Ria; L Adorini
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

10.  Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo.

Authors:  K Inaba; M Inaba; M Naito; R M Steinman
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  37 in total

1.  Study on immune function of dendritic cells in patients with esophageal carcinoma.

Authors:  Shen-Ren Chen; Yi-Ping Luo; Jin-Kun Zhang; Wei Yang; Zhi-Chao Zhen; Lin-Xin Chen; Wei Zhang
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

2.  Distinct chemokine and cytokine gene expression pattern of murine dendritic cells and macrophages in response to Mycobacterium tuberculosis infection.

Authors:  Sihyug Jang; Aleksandra Uzelac; Padmini Salgame
Journal:  J Leukoc Biol       Date:  2008-08-14       Impact factor: 4.962

3.  Cell wall glycolipids from Corynebacterium pseudotuberculosis strains with different virulences differ in terms of composition and immune recognition.

Authors:  Miriam Flores Rebouças; Dan Loureiro; Thiago Doria Barral; Nubia Seyffert; José Tadeu Raynal; Thiago Jesus Sousa; Henrique Cesar Pereira Figueiredo; Vasco Azevedo; Roberto Meyer; Ricardo Wagner Portela
Journal:  Braz J Microbiol       Date:  2020-07-25       Impact factor: 2.476

4.  Fate of Mycobacterium tuberculosis within murine dendritic cells.

Authors:  K A Bodnar; N V Serbina; J L Flynn
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Activation of murine dendritic cells and macrophages induced by Salmonella enterica serovar Typhimurium.

Authors:  Ruwani Sagarika Kalupahana; Pietro Mastroeni; Duncan Maskell; Barbara Ann Blacklaws
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

6.  Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis: activation of CD8+ cells, interferon-gamma recovery and reduction of lung injury.

Authors:  V L D Bonato; E D C Gonçalves; E G Soares; R R Santos Júnior; A Sartori; A A M Coelho-Castelo; C L Silva
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

Review 7.  Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence.

Authors:  Issar Smith
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

8.  New anti-tuberculosis agents amongst known drugs.

Authors:  Kathryn E A Lougheed; Debra L Taylor; Simon A Osborne; Justin S Bryans; Roger S Buxton
Journal:  Tuberculosis (Edinb)       Date:  2009-08-20       Impact factor: 3.131

9.  Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis.

Authors:  M Gonzalez-Juarrero; I M Orme
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

10.  Salmonella enterica serovar Typhimurium expressing mutant lipid A with decreased endotoxicity causes maturation of murine dendritic cells.

Authors:  Ruwani Kalupahana; A Romina Emilianus; Duncan Maskell; Barbara Blacklaws
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.